Figure 2.
(a) Percentage distribution of different SSRs; (b) Percentage distribution of mononucleotide SSRs; (c) Percentage distribution of drinucleotide SSRs; (d) Percentage distribution of trinucleotide SSRs; (e) Percentage distribution of tetranucleotide SSRs; (f) Percentage distribution of pentanucleotide SSRs; (g) Percentage distribution of hexanucleotide SSRs.